期刊文献+

临床患者血清CK-MB活性大于总肌酸激酶活性的生物学特征及原因分析 被引量:2

Biological Characteristics and Cause Analysis of Clinical Patients with Serum CK-MB-to-Total-CK Ratio More Than 1.0
下载PDF
导出
摘要 目的回顾性分析血清肌酸激酶同工酶(creatine kinase-MB,CK-MB)活性大于总肌酸激酶(creatine kinase,CK)活性的患者生物学特征及其原因。方法选取2017~2018年陕西省人民医院住院部29993例住院患者为研究对象,使用全自动生化分析仪速率法检测血清CK活性和免疫抑制法检测血清CK-MB活性,用统计学方法分析CK-MB>CK患者的生物学特征及产生的原因。结果在29993例患者中血清CK-MB>CK占0.81%(242/29993)。总体上在各年龄段中血清CK-MB>CK患者人数差异有统计学意义(χ^(2)=60.626,P=0.000),而且在各年龄段之间血清CK-MB>CK的男性和女性患者人数差异均有统计学意义(χ^(2)=24.787,46.206,均P=0.000);<15岁患者中血清CK-MB>MB人数最多。血清CK-MB>CK男性患者人数少于女性患者人数(45.87%vs 54.13%),差异具有统计学意义(χ^(2)=13.099,P=0.022),其中15~30岁组男性患者人数明显少于女性患者,差异有统计学意义(χ^(2)=6.962,P=0.008),其他年龄段男女患者人数差异无统计学意义(χ^(2)=0.249~3.931,均P>0.05)。血清CK-MB>CK患者所患疾病中,感染性疾病占44.2%(107/242),恶性肿瘤占20.7%(50/242),其他疾病共占35.1%(85/242)。结论明确血清CK-MB>CK患者生物学特征及与所患疾病的关系,有助于临床鉴别诊断相关疾病。 Objective Retrospective analysis on biological characteristics of patients with serum CK-MB-to-total-CK ratio more than 1.0(CK-MB>CK)was performed.Methods 29993 patients were recruited from inpatient departments of Shaanxi Provincial Hospital from January 2017 to December 2018.Serum CK activity and CK-MB activity were detected by automatic biochemical analyzer with rate method and immunosuppression methods,respectively.Results The patients with serum CKMB>CK accounted for 0.81%(242/29993).Generally,there existed statistical differences for the number of patients with serum CK-MB>CK between age groups(χ^(2)=60.626,P=0.000).There existed significantly statistical difference between age groups for male patients with serum CK-MB>CK(χ^(2)=24.787,P=0.000)as well as female ones(χ^(2)=46.206,P=0.000).There were the most male patients with CK-MB>CK younger than 15 years old as well as female ones(45.87%vs 54.13%).The male patients with CK-MB>CK was statistically less than that of female ones,the difference was significantly statistical(χ^(2)=13.099,P=0.022).The female patients aged from 10 to 15 years old with CK-MB>CK were more than those of male ones(χ^(2)=6.962,P=0.008)and there were no statistical differences between other age groups(χ^(2)=0.249~3.931,all P>0.05).44.2%(107/242)of patients with serum CK-MB>CK had infectious diseases,20.7%(50/242)malignant tumors and 35.1%(85/242)other diseases.Conclusion The investigation was helpful for further understanding biological characteristics of patients with serum CK-MB>CK and clinical differential diagnosis.
作者 张鹏 迟洁 白香妮 王银坤 郑霄 刘文康 ZHANG Peng;CHI Jie;BAI Xiang-ni;WANG Yin-kun;ZHENG Xiao;LIU Wen-kang(Department of Clinical Laboratory,Xi'an Trade Union Hospital,Xi’an 710100,China;Department of Clinical Laboratory,Shaanxi Provincial People’s Hospital,Xi’an 710068,China;Department of Clinical Laboratory,Xi’an XD Group Hospital,Xi’an 710077,China)
出处 《现代检验医学杂志》 CAS 2021年第6期116-119,共4页 Journal of Modern Laboratory Medicine
关键词 肌酸激酶活性(CK) 肌酸激酶同工酶(CK-MB) 生物学特征 creatine kinase creatine kinase(CK)-MB biological characteristics
  • 相关文献

参考文献7

二级参考文献35

  • 1顾亚明.轮状病毒肠炎与肠外脏器损害因素探讨[J].实用临床医药杂志,2006,10(2):95-96. 被引量:16
  • 2陆奎英.免疫抑制法检测血清肌酸激酶同工酶活性高于肌酸激酶总活性的原因探讨[J].国际检验医学杂志,2006,27(8):748-748. 被引量:4
  • 3吴凤丽,马晓光,孙玉珍,冯静文,张丽霞.血清CK-MB活力假性增高原因分析及临床意义[J].中国实验诊断学,2007,11(8):1041-1043. 被引量:34
  • 4顾兵.郑明华,陈兴国.检验与临床的沟通[M].北京:人民卫生出版社,2011.60.
  • 5林其燧 文庆成.临床化学诊断方法大全[M].北京:北京大学出版社,1990..
  • 6The development of clinical application and methodology of the detection on CK and CK-MB[J].Chinese Journal of Laboratory Medicine,2008,31(12):1418-1421.
  • 7Theres HP,Wagner KD,Romberg D,et al.Combined treatment with ramipril and metoprolol prevents changes in the creatine kinase isoenzyme system and improves hemodynamic function in rat hearts after myocardial infarction[J].Cardiovasc Drugs Ther,2000,14(6):597-606.
  • 8Gu B.The communication of clinical medicine and laboratory medicine[M].Beijing:People Hygiene Press,2011.
  • 9Tong MQ.The handbook of sample transfering[J].Beijing:People Hygiene Press,2010.
  • 10Kohli-Kochhar R,Mulwa E,Omuse G,et al.Macro CK in patients with elevated troponin I levels[J].Cardiovasc J Afr,2012,23(1):e7-e10.

共引文献32

同被引文献15

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部